SHIFT Newsroom · GLOBAL
Surgery and tirzepatide in advanced kidney disease: a simulation study
An American Journal of Surgery paper used a Markov model to project survival under different weight-management strategies for people with stage 5 chronic kidney disease.
An American Journal of Surgery paper used a Markov model to project survival under different weight-management strategies for people with stage 5 chronic kidney disease. Its outcomes are simulated, not observed survival results from a head-to-head patient trial. The projections depend on assumptions, including starting BMI and sustained weight loss. They cannot identify the best treatment for an individual.
SHIFT’s take
Read the study design and limits alongside the finding. This article does not determine individual treatment suitability.